RNAGene and PharmAbcine to develop novel mRNA therapeutics
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
The company plans to launch the product immediately
Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license
The drug is indicated for use in combination with other drugs
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
Sputnik Light is the first component of Sputnik V
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
The generic version of Sinequan, which is used for the treatment of anxiety, depression, and other target symptoms of psychoneurosis
Subscribe To Our Newsletter & Stay Updated